Top Banner
1 Financing Silicon Valley: Understanding Venture Capital and Making a Killer Pitch J. Alexander Sloan Partner Blackwolf Partners
30

Sloan killer presentations

Apr 08, 2018

Download

Documents

Raphael Kurian
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 1/30

1

Financing Silicon Valley:Understanding Venture Capital and 

Making a Killer Pitch

J. Alexander Sloan

Partner 

Blackwolf Partners

Page 2: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 2/30

2

Agenda

I. My Background

II. Some Basics on the Venture Business

III. Making a Killer Presentation

IV. Discussion

Page 3: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 3/30

3

My Experience and Perspective

1993 - 1996: The Vietnam Fund Limited

1996 - 1998: Cornell MBA

1999 - 2002: Hambrecht & Quist venture capital unit

Merged into J.P. Morgan Partners

Invested in many younger private technology companies

2004 on: Founding Partner, Blackwolf Partners

Early stage venture fund focus on Cleantech: healthier,

cleaner, more energy efficient products & services.

Board Member, Center for Sustainable Global Enterprise at JGSM

Page 4: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 4/30

4

Blackwolf Ventures$100 m. Tech Fund

driven by demands of:

Blackwolf Ventures$100 m. Tech Fund

driven by demands of:

Healthy Lifestyle(~33%)

Healthy Lifestyle(~33%)

Natural Resource

Sensibility(~33%)

Natural Resource

Sensibility(~33%)

Differentiated

Healthcare(~33%)

Differentiated

Healthcare(~33%)

• Food quality & choice• Clean air & water • Personal development

• Air & water utilization• Energy efficiency• Environmental management

• Healthcare solutions• Complimentary medicine• Cleaner Pharma

Clean TechnologiesClean Technologies

The Blackwolf Cleantech Strategy

Page 5: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 5/30

5

Company Stage

CapitalRequired IPO/Buy Out/Merger

Financing Lifecycle

Takes months to years to reach IPO/Buy Out

$25 m.

< $1 m.

$50 m. +

Startup Expansion Mid to Late Mezzanine Post IPO Mature

R  i  s k 

Capi

tal Req 

uired &

 Valua

tion

Page 6: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 6/30

6

Many Types of Financing Partners• Founders/bootstrap: entrepreneur and personal savings

• Angels: Individuals: “friends and family”“Bands of Angels”: informal groups of “professional” angels

• Specialized venture firms: smaller, more specialized: Blackwolf

• Traditional venture capital firms: Kleiner, Benchmark, Sequoia, etc.

• Strategic corporate: customers/suppliers who buy into the company.

• Corporate venture units: Intel Ventures, Nokia Ventures, etc.

• Investment banking venture: JP Morgan Partners, Goldman Sachs, etc.

• Investment banks: IPO underwriting.

• Public investors, public stock = currency.

• Debt instruments

 Don’t expect to get traditional venture funding…look for best option.

Page 7: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 7/30

7

“Valuation”: what is a company worth?

Public Company:• # shares outstanding X market price per share =

market capitalization = valuation.

• Stock price changes minute to minute, set in pubicmarket of buyers and sellers.

• This is an “indirect”, secondary market.

Private Company:

• # shares outstanding X negotiated price per share.• Transaction negotiated directly between investor and

owner, no “market clearing” mechanism.

Page 8: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 8/30

8

Fuzzy Math:The Mechanics of Valuation and Dilution

“Pre-Money” Valuation

( negotiated value for company)

+ Capital invested

= “Post Money” Valuation

(new valuation for company)

$10 million

$5 million

$15 million

• Investor now owes 5/15 or 33% of the company, and the prior

owners are “diluted” to 66% ownership.

• 33% of the company “cost” $5 m. But at a $20 m. “pre”, raising$5 m. only costs 20% of the company. Or 33% of the company at a$20 m. pre-money valuation raises $10 m.

Page 9: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 9/30

9

Organization & People

• Firm culture: ranges from small private partnership to more

corporate style.

• Decision making process: rule by consensus of all partners.

• the “Monday meeting”

• Partners have diverse backgrounds: technology, banking, consulting,

engineering, operating, sales, marketing and/or venture experience.

• Classic polarities to each partner’s investment approach:

quantitative versus qualitative appraisal.

• Business (MBA) versus technical (Ph.D.) perspective.

• Operating versus finance experience.

Page 10: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 10/30

10

What Value do Venture Investors Add afterthe Money is Invested?

• Board seat, guidance on strategy, check and balancefor management

• Accessing contracts/customers/introductions

• Hiring key managers

• Interaction with management

• Network of relationships and synergies between

portfolio companies

Long-term, involved, active partner…..(theoretically)

Page 11: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 11/30

11

Compensation to Venture Firm

1. Fees: 2% - 3% of committed capital, paid annually (covers

salaries, office, overhead, etc.).

2. Carried interest: 20% - 30% of profits after (and only if)

original capital is returned to investors.

• Fees can drive bigger fund size (bigger base) and faster

timing to raise the next fund (double dipping).

• Larger fund size can drive up average size of

investments sought: bigger bets.

Page 12: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 12/30

12

Exit and Timing are Key

We need to get our investment out of the company to make money.

• Primary means to exit: acquisition/trade sale or IPO.

• Time horizon from investment to exit: months to 5-7 years.

• Returns calculated and compensation paid to venture managers only

when cash or securities are actually distributed to investors.

$0

$5

$10

$15$20

$25

$30

$35

$40

$45

Ven

ture

Day

  of IPO

+30 

days

+12

0 da

ys

+36

5 da

ys

Co X Stock

• Lock-ups and other sellingrestrictions can dramaticallyaffect returns.

Page 13: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 13/30

II. Making Killer Presentations

So, you have:

a winning team, a compelling and practical product,

a clear business plan,

…and you want to pitch to a venture firm or 

other investor? 

Page 14: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 14/30

14

Your Overall Challenge

• You must clearly convey TWO value propositions:

1. To the customer

2. To the investor

• They are related but not the same.

• Convince me that both are highly attractive and likelyto be realized.

Page 15: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 15/30

15

Understand Your Audience

• Try to learn the backgrounds and perspectives of your expectedaudience.

• Research the firm’s website and Google the team.

– Prior successful and loser deals in your space?

– MBA or Ph.D. “mentality” or both?  Adjust your pitch.

– Understands your industry?

• In larger firms, an associate or EIR will likely meet with you first.Partners can drift in and out.

– Play to the firm’s point person. Get an advocate.

• No venture investor ever got fired for saying “Pass”.

Page 16: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 16/30

16

What Do Venture Investors Look for?

• Our Needs:– Company matches current Fund’s investment strategy and timing?

• The Opportunity:– What is the core business opportunity? How big?

• Management:– Great management team? Done this before? Done it together? Can I work

with them?

• Well Planned:– Clear business plan? Plan B & C?

– Unique approach/technology that can be defended?

• The “Deal”:

– Attractive price/valuation? Potential for up-rounds?– Extent of future financing needs before profitability?

– What are the exit opportunities, how long to get there?

You need to communicate answers clearly through a writtenbusiness plan and sharp presentation.

Page 17: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 17/30

17

General Tips to Knock Em Dead

• This is not a corporate presentation. Totally different dynamic.

• One hour (including Q&A), one shot.

• The audience is unprepared and has A.D.D. (and has a Blackberry

under the table).

• Expect to be interrupted.

• It’s not about your slides or your planned order. Feel the flow of 

each meeting. Give them what they want.

• Smile and make good eye contact.

• “Touch, Turn, Talk.”

Page 18: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 18/30

18

Interruptions & Flow Management

• You will be interrupted and asked questions out of your plannedsequence. Expect it, and go with it happily.

• Answer the question, then try to get back to your order.

• Be prepared to jump to a supporting “go-to” slide if askedsomething out of your planned order.– Have a printed reference guide of your slide order for yourself.

• A presentation is ideally a give and take of what you want to sayand the audience wants to hear.– Respect both.

• Go with the flow of each meeting, but maintain control.– Yes, it is a test…

• Watch your time.

Page 19: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 19/30

19

Manage Your Content

• Carefully balance your allocation (time and content) to:

1. Your market and its dynamics and opportunities.

2. Your product/service.

3. Competition: lessons, successes, opportunities.

4. Management team and advisors.5. Business model.

• If I don’t get the info, then you get zero credit for it.

Let’s discuss some additional venture investor-orientedneeds for each of these section…

Page 20: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 20/30

20

On slide 1 or 2, no later, explain:1. How big is the company: age, stage, # of employees,

product status, revenue/customers (if any)?

2. How much money has been raised/invested to date, when,valuations used?

3. How much investment are you looking for now?

First, Just the Facts…please!

Startup Mid to Late Post IPO

I need to put your company intoinvestment & portfolio context.

Don’t make me wait or dig for it. ?

? ?

?

Page 21: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 21/30

21

Market Opportunity

• Be highly specific to your product’s target market segment.

– Don’t just use the biggest market research numbers you can find.

– IDC and Gartner are often wrong…and we know it (just check our trackrecords).

• Who are your customers? Explain customers’ current buying behaviors.

• Where is their demand need/pain? What is the current solution? Whyis this solution insufficient?

• Go quickly into discussing your product as the solution.

Too much time is typically spent on this section. Keep moving.

Page 22: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 22/30

22

Your Product/Service

• What is the technology?– How does it work? Is it new or repurposed?

– Is it yours?

• What are the next phases/applications/opportunities foryour core product/service if Plan A fails?

• How will your product sell? Nice or need to have?– Push or Pull market dynamic? Build it and they will come?

– Did you start with a technology or with a market need?

• How will you defend your technology/advantage?– Patents: yeah, and….

Page 23: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 23/30

23

Business Model

• Gets the least attention in presentations. Get to it quickly.– Not just excel sheets at the back. Tell a story.

– Clearly walk through the growth milestones of the business:

• Capital needs, hiring, spending, inflection/decision points, alternatives...

• Reasonable projections and assumptions are moreimpressive (and believable) than highly optimistic ones.– Seen too many “hockey sticks”.

• What is Plan B and C for your technology/product?– Think about downside protection, not just upside.

– Investor is buying into the company, not into the product.

Page 24: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 24/30

24

More Business Model Questions

• How much money will this company need to get profitable?

• Minimum and maximum manageable investment load?– What would you do with 1/2 or 2x or 3x the money you are looking

for now?

• Can my fund invest its per deal minimum (could be up to$15-$20 m.) in this company within 3 years.

• Exit strategies are key. Investors need to get out. How?– IPO only? Trade sale options? Likely buyers?

– Comps of similar deals done?

– Timing counts. A fund has its own specific timing needs.

Page 25: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 25/30

25

Connect the Dots and Tell a StoryFYE FYE FYE FC Revised Projections

($ Millions) 6/30/02 6/30/03 6/30/04 (1) Year 1 (2) Year 2 Year 3 Year 4 Year 5

Revenue 5.4 4.8 6.6 10.8 16.5 23.2 29.4 35.0

Gross Profit 4.0 3.4 4.8 7.1 9.6 12.6 15.6 18.2

Gross Margin 74.1% 70.8% 72.7% 65.7% 58.2% 54.3% 53.1% 52.0%

Operating Expense 3.2 2.5 3.2 4.3 4.6 5.6 6.4 7.2

EBITDA 0.8 0.9 1.6 2.8 5.0 7.0 9.2 11.0

EBITDA Margin 14.8% 18.8% 24.2% 25.9% 30.3% 30.2% 31.3% 31.4%

(1) Preliminary, audit to be received prior to clos

(2) Revenue already under contract for year 1 is $7.6 million. Revenue relating to new system sales is projected to be $2.6 million.

  New rental contracts in year 1 are assumed to generate only 3 months of revenue for the year ($0.3 million).

Staff 8 12 25 30 40 55

Capital Invested 4,000,000$ -$ -$ 15,000,000$ -$ -$

Cash Burn/month 100,000$ 250,000$ 323,000$ 500,000$ 800,000$ 1,200,000$

Cash Burn/year 1,200,000$ 3,000,000$ 3,876,000$ 6,000,000$ 9,600,000$ 14,400,000$

Cash Balance 2,800,000$ 1,000,000$ 124,000$ 9,000,000$ 5,400,000$ 600,000$

v1.0 v1.5 V 2.0Product

2005 2006 2007 2008 2009 2010 2011 2012

Exit Plan M&A IPO

Page 26: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 26/30

26

Explain Your Competition

• Who is doing your business idea now?

• What do they do wrong or right? What have they taughtyou?

• Very few new companies have no competition. If youhave none, then are you smart or dumb for entering thespace?

• Is your competition a potential threat, partner, targetor source of acquisition…or all of those? How will you

manage this?

• Know case studies of your product area and industrythat show success, including a money-making exit forinvestor.

Page 27: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 27/30

27

The Team• Backgrounds? Done this sector/product before?

• Worked together before?

• Made mistakes before? Learned what?

• Made money for investors before?

• Worked in startup, midsized, and/or larger companies?

• Worked with venture investors before? Whom?

• Relevant connections to this industry and product?

• Board of directors, advisors and investors?

Page 28: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 28/30

28

The Softer Stuff

• Venture decisions are made on imperfect, “soft”qualitative data, this applies to decisions about workingwith people.

• Personality & chemistry matters.– Do I want to work with you for years, through tough times?

– Let your personality come through.

– Do you know your stuff?

– How well and openly do you respond to questions?

– Are you honest about weaknesses and needs?

• Is this just a one-person show?

Page 29: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 29/30

29

Talking Valuation

A venture investor will ask,

“So, what do you think your company is worth today?”

Yes, it’s a sucker question, but be ready:

• Have a reasonable pre-money valuation range prepared.

• Have a plausible answer related to the current status ofthe product, sales and business.

• We love “comps”. Be ready with some examples andstories.

Page 30: Sloan killer presentations

8/7/2019 Sloan killer presentations

http://slidepdf.com/reader/full/sloan-killer-presentations 30/30

30

Summary• Much easier for a venture investor to say “no” to a deal.

• Lots of deals come our way. You need to stand out.

• Great presentations are honest, clear, exciting, direct and flexible.

• It’s about the business opportunity, not just cool technology.

– We call it a “deal” for a reason.

• How can an investor buy low and sell high, and on time?

• Avoid seeking professional money until you have to (or never at all).

• Choose your investors as carefully as we choose you.

Thanks for your attention!